Norway Pharmaceuticals & Healthcare Q4 2018
Norway's pharmaceutical and healthcare spending will continue to increase over the next 10 years, creatingopportunities for drugmakers and healthcare providers. Moreover, robust economic growth will underpin an improved fiscal outlookover the coming quarters, while the government will continue to support health industries development. That said, Norway’s smallpharmaceutical market size relative to regional peers, combined with cost control measures, will keep a lid on opportunitiespresented to drugmakers.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook